115480 — CU Medical Systems Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual income statement for CU Medical Systems, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	35,402	46,957	41,803	40,629	48,223
Cost of Revenue
Gross Profit	18,476	24,701	20,403	21,545	28,513
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	37,116	36,462	39,518	33,480	37,409
Operating Profit	-1,714	10,496	2,285	7,149	10,813
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-15,140	10,446	-7,443	-2,474	1,509
Provision for Income Taxes
Net Income After Taxes	-14,141	9,511	-8,136	-3,141	819
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-13,981	9,425	-8,204	-3,204	819
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-13,981	9,425	-8,204	-3,204	819
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,202	1,020	-678	-269	67.5
Dividends per Share